Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock
Catheterization and Cardiovascular Interventions · 2026-08 · 108 (2) · 483-488
DOI: 10.1002/ccd.70678 ↗Kurz gefasst
Fallbericht in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 27.05.2026. Verfasst von Tobias Reithmayer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Mitral Valve Insufficiency, Cardiac Catheterization, Mitral Valve. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce. Case Summary We report the case of a 48‐year‐old male patient who was admitted to our hospital with cardiogenic shock, first diagnosis of dilated cardiomyopathy and severe ventricular SMR in August 2016. With the use of mechanical circulatory support, the patient underwent urgent M‐TEER with implantation of one MitraClip device, reducing MR from severe to mild‐to‐moderate. At 9‐year follow‐up in 2025 and consequent optimization of guideline directed medical therapy, the patient remains clinically stable, with sustained MR reduction and good device function.
Discussion
This case highlights the durability of M‐TEER even in a critically ill patient initially presenting with cardiogenic shock and multiorgan failure. To our knowledge, this represents one of the longest follow‐up observations after M‐TEER, supporting its role as a durable treatment strategy in high‐risk patients.
Conclusions
M‐TEER can achieve durable long‐term MR reduction and symptomatic benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Munich, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
ORCID-Profile: Philipp M Doldi
Zitieren
APA
Reithmayer, T., Stocker, T. J., Weckbach, L. T., Novotny, J., Doldi, P. M., Kempton, H., Massberg, S., Näbauer, M., Hausleiter, J., & Stolz, L. (2026). Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock. Catheterization and Cardiovascular Interventions, 108(2), 483-488. https://doi.org/10.1002/ccd.70678
Vancouver
Reithmayer T, Stocker TJ, Weckbach LT, Novotny J, Doldi PM, Kempton H, et al. Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock. Catheterization and Cardiovascular Interventions. 2026;108(2):483-488. doi:10.1002/ccd.70678
BibTeX
@article{Reithmayer2026,
author = {Reithmayer, Tobias and Stocker, Thomas J and Weckbach, Ludwig T and Novotny, Julia and Doldi, Philipp M and Kempton, Hannah and Massberg, Steffen and Näbauer, Michael and Hausleiter, Jörg and Stolz, Lukas},
title = {Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {108},
number = {2},
pages = {483--488},
doi = {10.1002/ccd.70678}
}
EUVIMED